
These phase 3 EXCALIBER-RRMM findings build on earlier MRD-negative complete response results supporting FDA approval of the iberdomide-based regimen.
Supplements and Featured Publications
over 29 years ago
Goals and Objectivesover 29 years ago
Before the Heart Attack: Prevention of Acute Myocardial Infarctionover 29 years ago
After the Heart Attack: Treatment of Acute Myocardial Infarctionover 29 years ago
Selected Abstractsover 29 years ago
CME Quizover 29 years ago
Bibliographyover 29 years ago
Participants




